Global Cell Therapy Market by Manufacturers, Countries, Type and Application, Forecast to 2023
Cell therapy (also called cellular therapy or cytotherapy) is therapy in which cellular material is injected into a patient; this generally means intact, living cells. For example, T cells capable of fighting cancer cells via cell-mediated immunity may be injected in the course of immunotherapy.
Scope of the Report:
This report studies the Cell Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cell Therapy market by product type and applications/end industries.
Cell therapy products, which are derived from stem cells, tissues, and organs grown in laboratories, are injected into patients. The growing number of clinical trials, government and private funding, and increasing number of partnerships between companies are driving the growth of the global cell therapy market. Cell therapy products that are available in the market are based on autologous and allogenic cells. The demand of cell therapy treatment is increasing. This is because cell therapy products can be used for personalized treatment.
The global Cell Therapy market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cell Therapy.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Scope of the Report:
This report studies the Cell Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cell Therapy market by product type and applications/end industries.
Cell therapy products, which are derived from stem cells, tissues, and organs grown in laboratories, are injected into patients. The growing number of clinical trials, government and private funding, and increasing number of partnerships between companies are driving the growth of the global cell therapy market. Cell therapy products that are available in the market are based on autologous and allogenic cells. The demand of cell therapy treatment is increasing. This is because cell therapy products can be used for personalized treatment.
The global Cell Therapy market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cell Therapy.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
- Dendreon
- Mesoblast
- Vericel
- Novartis AG
- GlaxoSmithKline plc
- MEDIPOST
- Osiris
- PHARMICELL
- NuVasive, Inc.
- JCR Pharmaceuticals Co., Ltd
- ANTEROGEN.CO.,LTD.
- Cynata
- CELLECTIS
- BioNTech IMFS
- EUFETS GmbH
- Cognate
- Pluristem
- Grupo Praxis
- Genzyme Corporation
- Advanced Tissue
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Autologous
- Allogeneic
- Hospitals and clinics
- ASCs
- Regenerative medicine centers
1 CELL THERAPY MARKET OVERVIEW
1.1 Product Overview and Scope of Cell Therapy
1.2 Classification of Cell Therapy by Types
1.2.1 Global Cell Therapy Revenue Comparison by Types (2017-2023)
1.2.2 Global Cell Therapy Revenue Market Share by Types in 2017
1.2.3 Autologous
1.2.4 Allogeneic
1.3 Global Cell Therapy Market by Application
1.3.1 Global Cell Therapy Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals and clinics
1.3.3 ASCs
1.3.4 Regenerative medicine centers
1.4 Global Cell Therapy Market by Regions
1.4.1 Global Cell Therapy Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Cell Therapy Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cell Therapy Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cell Therapy Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Cell Therapy Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cell Therapy Status and Prospect (2013-2023)
1.5 Global Market Size of Cell Therapy (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Dendreon
2.1.1 Business Overview
2.1.2 Cell Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Dendreon Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.2 Mesoblast
2.2.1 Business Overview
2.2.2 Cell Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Mesoblast Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.3 Vericel
2.3.1 Business Overview
2.3.2 Cell Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Vericel Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis AG
2.4.1 Business Overview
2.4.2 Cell Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis AG Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.5 GlaxoSmithKline plc
2.5.1 Business Overview
2.5.2 Cell Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GlaxoSmithKline plc Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.6 MEDIPOST
2.6.1 Business Overview
2.6.2 Cell Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 MEDIPOST Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.7 Osiris
2.7.1 Business Overview
2.7.2 Cell Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Osiris Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.8 PHARMICELL
2.8.1 Business Overview
2.8.2 Cell Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 PHARMICELL Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.9 NuVasive, Inc.
2.9.1 Business Overview
2.9.2 Cell Therapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 NuVasive, Inc. Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.10 JCR Pharmaceuticals Co., Ltd
2.10.1 Business Overview
2.10.2 Cell Therapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 JCR Pharmaceuticals Co., Ltd Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.11 ANTEROGEN.CO.,LTD.
2.11.1 Business Overview
2.11.2 Cell Therapy Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 ANTEROGEN.CO.,LTD. Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.12 Cynata
2.12.1 Business Overview
2.12.2 Cell Therapy Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Cynata Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.13 CELLECTIS
2.13.1 Business Overview
2.13.2 Cell Therapy Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 CELLECTIS Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.14 BioNTech IMFS
2.14.1 Business Overview
2.14.2 Cell Therapy Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 BioNTech IMFS Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.15 EUFETS GmbH
2.15.1 Business Overview
2.15.2 Cell Therapy Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 EUFETS GmbH Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.16 Cognate
2.16.1 Business Overview
2.16.2 Cell Therapy Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Cognate Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.17 Pluristem
2.17.1 Business Overview
2.17.2 Cell Therapy Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Pluristem Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.18 Grupo Praxis
2.18.1 Business Overview
2.18.2 Cell Therapy Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Grupo Praxis Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.19 Genzyme Corporation
2.19.1 Business Overview
2.19.2 Cell Therapy Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Genzyme Corporation Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.20 Advanced Tissue
2.20.1 Business Overview
2.20.2 Cell Therapy Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Advanced Tissue Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL CELL THERAPY MARKET COMPETITION, BY PLAYERS
3.1 Global Cell Therapy Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Cell Therapy Players Market Share
3.2.2 Top 10 Cell Therapy Players Market Share
3.3 Market Competition Trend
4 GLOBAL CELL THERAPY MARKET SIZE BY REGIONS
4.1 Global Cell Therapy Revenue and Market Share by Regions
4.2 North America Cell Therapy Revenue and Growth Rate (2013-2018)
4.3 Europe Cell Therapy Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Cell Therapy Revenue and Growth Rate (2013-2018)
4.5 South America Cell Therapy Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Cell Therapy Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA CELL THERAPY REVENUE BY COUNTRIES
5.1 North America Cell Therapy Revenue by Countries (2013-2018)
5.2 USA Cell Therapy Revenue and Growth Rate (2013-2018)
5.3 Canada Cell Therapy Revenue and Growth Rate (2013-2018)
5.4 Mexico Cell Therapy Revenue and Growth Rate (2013-2018)
6 EUROPE CELL THERAPY REVENUE BY COUNTRIES
6.1 Europe Cell Therapy Revenue by Countries (2013-2018)
6.2 Germany Cell Therapy Revenue and Growth Rate (2013-2018)
6.3 UK Cell Therapy Revenue and Growth Rate (2013-2018)
6.4 France Cell Therapy Revenue and Growth Rate (2013-2018)
6.5 Russia Cell Therapy Revenue and Growth Rate (2013-2018)
6.6 Italy Cell Therapy Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC CELL THERAPY REVENUE BY COUNTRIES
7.1 Asia-Pacific Cell Therapy Revenue by Countries (2013-2018)
7.2 China Cell Therapy Revenue and Growth Rate (2013-2018)
7.3 Japan Cell Therapy Revenue and Growth Rate (2013-2018)
7.4 Korea Cell Therapy Revenue and Growth Rate (2013-2018)
7.5 India Cell Therapy Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Cell Therapy Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA CELL THERAPY REVENUE BY COUNTRIES
8.1 South America Cell Therapy Revenue by Countries (2013-2018)
8.2 Brazil Cell Therapy Revenue and Growth Rate (2013-2018)
8.3 Argentina Cell Therapy Revenue and Growth Rate (2013-2018)
8.4 Colombia Cell Therapy Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE CELL THERAPY BY COUNTRIES
9.1 Middle East and Africa Cell Therapy Revenue by Countries (2013-2018)
9.2 Saudi Arabia Cell Therapy Revenue and Growth Rate (2013-2018)
9.3 UAE Cell Therapy Revenue and Growth Rate (2013-2018)
9.4 Egypt Cell Therapy Revenue and Growth Rate (2013-2018)
9.5 Nigeria Cell Therapy Revenue and Growth Rate (2013-2018)
9.6 South Africa Cell Therapy Revenue and Growth Rate (2013-2018)
10 GLOBAL CELL THERAPY MARKET SEGMENT BY TYPE
10.1 Global Cell Therapy Revenue and Market Share by Type (2013-2018)
10.2 Global Cell Therapy Market Forecast by Type (2018-2023)
10.3 Autologous Revenue Growth Rate (2013-2023)
10.4 Allogeneic Revenue Growth Rate (2013-2023)
11 GLOBAL CELL THERAPY MARKET SEGMENT BY APPLICATION
11.1 Global Cell Therapy Revenue Market Share by Application (2013-2018)
11.2 Cell Therapy Market Forecast by Application (2018-2023)
11.3 Hospitals and clinics Revenue Growth (2013-2018)
11.4 ASCs Revenue Growth (2013-2018)
11.5 Regenerative medicine centers Revenue Growth (2013-2018)
12 GLOBAL CELL THERAPY MARKET SIZE FORECAST (2018-2023)
12.1 Global Cell Therapy Market Size Forecast (2018-2023)
12.2 Global Cell Therapy Market Forecast by Regions (2018-2023)
12.3 North America Cell Therapy Revenue Market Forecast (2018-2023)
12.4 Europe Cell Therapy Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Cell Therapy Revenue Market Forecast (2018-2023)
12.6 South America Cell Therapy Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Cell Therapy Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
1.1 Product Overview and Scope of Cell Therapy
1.2 Classification of Cell Therapy by Types
1.2.1 Global Cell Therapy Revenue Comparison by Types (2017-2023)
1.2.2 Global Cell Therapy Revenue Market Share by Types in 2017
1.2.3 Autologous
1.2.4 Allogeneic
1.3 Global Cell Therapy Market by Application
1.3.1 Global Cell Therapy Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals and clinics
1.3.3 ASCs
1.3.4 Regenerative medicine centers
1.4 Global Cell Therapy Market by Regions
1.4.1 Global Cell Therapy Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Cell Therapy Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cell Therapy Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cell Therapy Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Cell Therapy Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cell Therapy Status and Prospect (2013-2023)
1.5 Global Market Size of Cell Therapy (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Dendreon
2.1.1 Business Overview
2.1.2 Cell Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Dendreon Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.2 Mesoblast
2.2.1 Business Overview
2.2.2 Cell Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Mesoblast Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.3 Vericel
2.3.1 Business Overview
2.3.2 Cell Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Vericel Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis AG
2.4.1 Business Overview
2.4.2 Cell Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis AG Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.5 GlaxoSmithKline plc
2.5.1 Business Overview
2.5.2 Cell Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GlaxoSmithKline plc Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.6 MEDIPOST
2.6.1 Business Overview
2.6.2 Cell Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 MEDIPOST Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.7 Osiris
2.7.1 Business Overview
2.7.2 Cell Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Osiris Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.8 PHARMICELL
2.8.1 Business Overview
2.8.2 Cell Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 PHARMICELL Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.9 NuVasive, Inc.
2.9.1 Business Overview
2.9.2 Cell Therapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 NuVasive, Inc. Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.10 JCR Pharmaceuticals Co., Ltd
2.10.1 Business Overview
2.10.2 Cell Therapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 JCR Pharmaceuticals Co., Ltd Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.11 ANTEROGEN.CO.,LTD.
2.11.1 Business Overview
2.11.2 Cell Therapy Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 ANTEROGEN.CO.,LTD. Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.12 Cynata
2.12.1 Business Overview
2.12.2 Cell Therapy Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Cynata Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.13 CELLECTIS
2.13.1 Business Overview
2.13.2 Cell Therapy Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 CELLECTIS Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.14 BioNTech IMFS
2.14.1 Business Overview
2.14.2 Cell Therapy Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 BioNTech IMFS Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.15 EUFETS GmbH
2.15.1 Business Overview
2.15.2 Cell Therapy Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 EUFETS GmbH Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.16 Cognate
2.16.1 Business Overview
2.16.2 Cell Therapy Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Cognate Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.17 Pluristem
2.17.1 Business Overview
2.17.2 Cell Therapy Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Pluristem Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.18 Grupo Praxis
2.18.1 Business Overview
2.18.2 Cell Therapy Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Grupo Praxis Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.19 Genzyme Corporation
2.19.1 Business Overview
2.19.2 Cell Therapy Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Genzyme Corporation Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.20 Advanced Tissue
2.20.1 Business Overview
2.20.2 Cell Therapy Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Advanced Tissue Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL CELL THERAPY MARKET COMPETITION, BY PLAYERS
3.1 Global Cell Therapy Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Cell Therapy Players Market Share
3.2.2 Top 10 Cell Therapy Players Market Share
3.3 Market Competition Trend
4 GLOBAL CELL THERAPY MARKET SIZE BY REGIONS
4.1 Global Cell Therapy Revenue and Market Share by Regions
4.2 North America Cell Therapy Revenue and Growth Rate (2013-2018)
4.3 Europe Cell Therapy Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Cell Therapy Revenue and Growth Rate (2013-2018)
4.5 South America Cell Therapy Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Cell Therapy Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA CELL THERAPY REVENUE BY COUNTRIES
5.1 North America Cell Therapy Revenue by Countries (2013-2018)
5.2 USA Cell Therapy Revenue and Growth Rate (2013-2018)
5.3 Canada Cell Therapy Revenue and Growth Rate (2013-2018)
5.4 Mexico Cell Therapy Revenue and Growth Rate (2013-2018)
6 EUROPE CELL THERAPY REVENUE BY COUNTRIES
6.1 Europe Cell Therapy Revenue by Countries (2013-2018)
6.2 Germany Cell Therapy Revenue and Growth Rate (2013-2018)
6.3 UK Cell Therapy Revenue and Growth Rate (2013-2018)
6.4 France Cell Therapy Revenue and Growth Rate (2013-2018)
6.5 Russia Cell Therapy Revenue and Growth Rate (2013-2018)
6.6 Italy Cell Therapy Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC CELL THERAPY REVENUE BY COUNTRIES
7.1 Asia-Pacific Cell Therapy Revenue by Countries (2013-2018)
7.2 China Cell Therapy Revenue and Growth Rate (2013-2018)
7.3 Japan Cell Therapy Revenue and Growth Rate (2013-2018)
7.4 Korea Cell Therapy Revenue and Growth Rate (2013-2018)
7.5 India Cell Therapy Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Cell Therapy Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA CELL THERAPY REVENUE BY COUNTRIES
8.1 South America Cell Therapy Revenue by Countries (2013-2018)
8.2 Brazil Cell Therapy Revenue and Growth Rate (2013-2018)
8.3 Argentina Cell Therapy Revenue and Growth Rate (2013-2018)
8.4 Colombia Cell Therapy Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE CELL THERAPY BY COUNTRIES
9.1 Middle East and Africa Cell Therapy Revenue by Countries (2013-2018)
9.2 Saudi Arabia Cell Therapy Revenue and Growth Rate (2013-2018)
9.3 UAE Cell Therapy Revenue and Growth Rate (2013-2018)
9.4 Egypt Cell Therapy Revenue and Growth Rate (2013-2018)
9.5 Nigeria Cell Therapy Revenue and Growth Rate (2013-2018)
9.6 South Africa Cell Therapy Revenue and Growth Rate (2013-2018)
10 GLOBAL CELL THERAPY MARKET SEGMENT BY TYPE
10.1 Global Cell Therapy Revenue and Market Share by Type (2013-2018)
10.2 Global Cell Therapy Market Forecast by Type (2018-2023)
10.3 Autologous Revenue Growth Rate (2013-2023)
10.4 Allogeneic Revenue Growth Rate (2013-2023)
11 GLOBAL CELL THERAPY MARKET SEGMENT BY APPLICATION
11.1 Global Cell Therapy Revenue Market Share by Application (2013-2018)
11.2 Cell Therapy Market Forecast by Application (2018-2023)
11.3 Hospitals and clinics Revenue Growth (2013-2018)
11.4 ASCs Revenue Growth (2013-2018)
11.5 Regenerative medicine centers Revenue Growth (2013-2018)
12 GLOBAL CELL THERAPY MARKET SIZE FORECAST (2018-2023)
12.1 Global Cell Therapy Market Size Forecast (2018-2023)
12.2 Global Cell Therapy Market Forecast by Regions (2018-2023)
12.3 North America Cell Therapy Revenue Market Forecast (2018-2023)
12.4 Europe Cell Therapy Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Cell Therapy Revenue Market Forecast (2018-2023)
12.6 South America Cell Therapy Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Cell Therapy Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
LIST OF TABLES AND FIGURES
Figure Cell Therapy Picture
Table Product Specifications of Cell Therapy
Table Global Cell Therapy and Revenue (Million USD) Market Split by Product Type
Figure Global Cell Therapy Revenue Market Share by Types in 2017
Figure Autologous Picture
Figure Allogeneic Picture
Table Global Cell Therapy Revenue (Million USD) by Application (2013-2023)
Figure Cell Therapy Revenue Market Share by Applications in 2017
Figure Hospitals and clinics Picture
Figure ASCs Picture
Figure Regenerative medicine centers Picture
Table Global Market Cell Therapy Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Cell Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Cell Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Cell Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Cell Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Cell Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Cell Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Table Dendreon Basic Information, Manufacturing Base and Competitors
Table Dendreon Cell Therapy Type and Applications
Table Dendreon Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Mesoblast Basic Information, Manufacturing Base and Competitors
Table Mesoblast Cell Therapy Type and Applications
Table Mesoblast Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Vericel Basic Information, Manufacturing Base and Competitors
Table Vericel Cell Therapy Type and Applications
Table Vericel Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Cell Therapy Type and Applications
Table Novartis AG Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline plc Cell Therapy Type and Applications
Table GlaxoSmithKline plc Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table MEDIPOST Basic Information, Manufacturing Base and Competitors
Table MEDIPOST Cell Therapy Type and Applications
Table MEDIPOST Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Osiris Basic Information, Manufacturing Base and Competitors
Table Osiris Cell Therapy Type and Applications
Table Osiris Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table PHARMICELL Basic Information, Manufacturing Base and Competitors
Table PHARMICELL Cell Therapy Type and Applications
Table PHARMICELL Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table NuVasive, Inc. Basic Information, Manufacturing Base and Competitors
Table NuVasive, Inc. Cell Therapy Type and Applications
Table NuVasive, Inc. Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table JCR Pharmaceuticals Co., Ltd Basic Information, Manufacturing Base and Competitors
Table JCR Pharmaceuticals Co., Ltd Cell Therapy Type and Applications
Table JCR Pharmaceuticals Co., Ltd Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table ANTEROGEN.CO.,LTD. Basic Information, Manufacturing Base and Competitors
Table ANTEROGEN.CO.,LTD. Cell Therapy Type and Applications
Table ANTEROGEN.CO.,LTD. Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Cynata Basic Information, Manufacturing Base and Competitors
Table Cynata Cell Therapy Type and Applications
Table Cynata Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table CELLECTIS Basic Information, Manufacturing Base and Competitors
Table CELLECTIS Cell Therapy Type and Applications
Table CELLECTIS Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table BioNTech IMFS Basic Information, Manufacturing Base and Competitors
Table BioNTech IMFS Cell Therapy Type and Applications
Table BioNTech IMFS Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table EUFETS GmbH Basic Information, Manufacturing Base and Competitors
Table EUFETS GmbH Cell Therapy Type and Applications
Table EUFETS GmbH Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Cognate Basic Information, Manufacturing Base and Competitors
Table Cognate Cell Therapy Type and Applications
Table Cognate Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Pluristem Basic Information, Manufacturing Base and Competitors
Table Pluristem Cell Therapy Type and Applications
Table Pluristem Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Grupo Praxis Basic Information, Manufacturing Base and Competitors
Table Grupo Praxis Cell Therapy Type and Applications
Table Grupo Praxis Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Genzyme Corporation Basic Information, Manufacturing Base and Competitors
Table Genzyme Corporation Cell Therapy Type and Applications
Table Genzyme Corporation Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Advanced Tissue Basic Information, Manufacturing Base and Competitors
Table Advanced Tissue Cell Therapy Type and Applications
Table Advanced Tissue Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Global Cell Therapy Revenue (Million USD) by Players (2013-2018)
Table Global Cell Therapy Revenue Share by Players (2013-2018)
Figure Global Cell Therapy Revenue Share by Players in 2016
Figure Global Cell Therapy Revenue Share by Players in 2017
Figure Global Top 5 Players Cell Therapy Revenue Market Share in 2017
Figure Global Top 10 Players Cell Therapy Revenue Market Share in 2017
Figure Global Cell Therapy Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Cell Therapy Revenue (Million USD) by Regions (2013-2018)
Table Global Cell Therapy Revenue Market Share by Regions (2013-2018)
Figure Global Cell Therapy Revenue Market Share by Regions (2013-2018)
Figure Global Cell Therapy Revenue Market Share by Regions in 2017
Figure North America Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Europe Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Cell Therapy Revenue and Growth Rate (2013-2018)
Figure South America Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Cell Therapy Revenue and Growth Rate (2013-2018)
Table North America Cell Therapy Revenue by Countries (2013-2018)
Table North America Cell Therapy Revenue Market Share by Countries (2013-2018)
Figure North America Cell Therapy Revenue Market Share by Countries (2013-2018)
Figure North America Cell Therapy Revenue Market Share by Countries in 2017
Figure USA Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Canada Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Mexico Cell Therapy Revenue and Growth Rate (2013-2018)
Table Europe Cell Therapy Revenue (Million USD) by Countries (2013-2018)
Figure Europe Cell Therapy Revenue Market Share by Countries (2013-2018)
Figure Europe Cell Therapy Revenue Market Share by Countries in 2017
Figure Germany Cell Therapy Revenue and Growth Rate (2013-2018)
Figure UK Cell Therapy Revenue and Growth Rate (2013-2018)
Figure France Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Russia Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Italy Cell Therapy Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Cell Therapy Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Cell Therapy Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Cell Therapy Revenue Market Share by Countries in 2017
Figure China Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Japan Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Korea Cell Therapy Revenue and Growth Rate (2013-2018)
Figure India Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Cell Therapy Revenue and Growth Rate (2013-2018)
Table South America Cell Therapy Revenue by Countries (2013-2018)
Table South America Cell Therapy Revenue Market Share by Countries (2013-2018)
Figure South America Cell Therapy Revenue Market Share by Countries (2013-2018)
Figure South America Cell Therapy Revenue Market Share by Countries in 2017
Figure Brazil Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Argentina Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Colombia Cell Therapy Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Cell Therapy Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Cell Therapy Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Cell Therapy Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Cell Therapy Revenue Market Share by Countries in 2017
Figure Saudi Arabia Cell Therapy Revenue and Growth Rate (2013-2018)
Figure UAE Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Egypt Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Nigeria Cell Therapy Revenue and Growth Rate (2013-2018)
Figure South Africa Cell Therapy Revenue and Growth Rate (2013-2018)
Table Global Cell Therapy Revenue (Million USD) by Type (2013-2018)
Table Global Cell Therapy Revenue Share by Type (2013-2018)
Figure Global Cell Therapy Revenue Share by Type (2013-2018)
Figure Global Cell Therapy Revenue Share by Type in 2017
Table Global Cell Therapy Revenue Forecast by Type (2018-2023)
Figure Global Cell Therapy Market Share Forecast by Type (2018-2023)
Figure Global Autologous Revenue Growth Rate (2013-2018)
Figure Global Allogeneic Revenue Growth Rate (2013-2018)
Table Global Cell Therapy Revenue by Application (2013-2018)
Table Global Cell Therapy Revenue Share by Application (2013-2018)
Figure Global Cell Therapy Revenue Share by Application (2013-2018)
Figure Global Cell Therapy Revenue Share by Application in 2017
Table Global Cell Therapy Revenue Forecast by Application (2018-2023)
Figure Global Cell Therapy Market Share Forecast by Application (2018-2023)
Figure Global Hospitals and clinics Revenue Growth Rate (2013-2018)
Figure Global ASCs Revenue Growth Rate (2013-2018)
Figure Global Regenerative medicine centers Revenue Growth Rate (2013-2018)
Figure Global Cell Therapy Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Cell Therapy Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Cell Therapy Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Cell Therapy Revenue Market Forecast (2018-2023)
Figure Europe Cell Therapy Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Cell Therapy Revenue Market Forecast (2018-2023)
Figure South America Cell Therapy Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Cell Therapy Revenue Market Forecast (2018-2023)
Figure Cell Therapy Picture
Table Product Specifications of Cell Therapy
Table Global Cell Therapy and Revenue (Million USD) Market Split by Product Type
Figure Global Cell Therapy Revenue Market Share by Types in 2017
Figure Autologous Picture
Figure Allogeneic Picture
Table Global Cell Therapy Revenue (Million USD) by Application (2013-2023)
Figure Cell Therapy Revenue Market Share by Applications in 2017
Figure Hospitals and clinics Picture
Figure ASCs Picture
Figure Regenerative medicine centers Picture
Table Global Market Cell Therapy Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Cell Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Cell Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Cell Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Cell Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Cell Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Cell Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Table Dendreon Basic Information, Manufacturing Base and Competitors
Table Dendreon Cell Therapy Type and Applications
Table Dendreon Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Mesoblast Basic Information, Manufacturing Base and Competitors
Table Mesoblast Cell Therapy Type and Applications
Table Mesoblast Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Vericel Basic Information, Manufacturing Base and Competitors
Table Vericel Cell Therapy Type and Applications
Table Vericel Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Cell Therapy Type and Applications
Table Novartis AG Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline plc Cell Therapy Type and Applications
Table GlaxoSmithKline plc Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table MEDIPOST Basic Information, Manufacturing Base and Competitors
Table MEDIPOST Cell Therapy Type and Applications
Table MEDIPOST Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Osiris Basic Information, Manufacturing Base and Competitors
Table Osiris Cell Therapy Type and Applications
Table Osiris Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table PHARMICELL Basic Information, Manufacturing Base and Competitors
Table PHARMICELL Cell Therapy Type and Applications
Table PHARMICELL Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table NuVasive, Inc. Basic Information, Manufacturing Base and Competitors
Table NuVasive, Inc. Cell Therapy Type and Applications
Table NuVasive, Inc. Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table JCR Pharmaceuticals Co., Ltd Basic Information, Manufacturing Base and Competitors
Table JCR Pharmaceuticals Co., Ltd Cell Therapy Type and Applications
Table JCR Pharmaceuticals Co., Ltd Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table ANTEROGEN.CO.,LTD. Basic Information, Manufacturing Base and Competitors
Table ANTEROGEN.CO.,LTD. Cell Therapy Type and Applications
Table ANTEROGEN.CO.,LTD. Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Cynata Basic Information, Manufacturing Base and Competitors
Table Cynata Cell Therapy Type and Applications
Table Cynata Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table CELLECTIS Basic Information, Manufacturing Base and Competitors
Table CELLECTIS Cell Therapy Type and Applications
Table CELLECTIS Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table BioNTech IMFS Basic Information, Manufacturing Base and Competitors
Table BioNTech IMFS Cell Therapy Type and Applications
Table BioNTech IMFS Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table EUFETS GmbH Basic Information, Manufacturing Base and Competitors
Table EUFETS GmbH Cell Therapy Type and Applications
Table EUFETS GmbH Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Cognate Basic Information, Manufacturing Base and Competitors
Table Cognate Cell Therapy Type and Applications
Table Cognate Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Pluristem Basic Information, Manufacturing Base and Competitors
Table Pluristem Cell Therapy Type and Applications
Table Pluristem Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Grupo Praxis Basic Information, Manufacturing Base and Competitors
Table Grupo Praxis Cell Therapy Type and Applications
Table Grupo Praxis Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Genzyme Corporation Basic Information, Manufacturing Base and Competitors
Table Genzyme Corporation Cell Therapy Type and Applications
Table Genzyme Corporation Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Advanced Tissue Basic Information, Manufacturing Base and Competitors
Table Advanced Tissue Cell Therapy Type and Applications
Table Advanced Tissue Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Global Cell Therapy Revenue (Million USD) by Players (2013-2018)
Table Global Cell Therapy Revenue Share by Players (2013-2018)
Figure Global Cell Therapy Revenue Share by Players in 2016
Figure Global Cell Therapy Revenue Share by Players in 2017
Figure Global Top 5 Players Cell Therapy Revenue Market Share in 2017
Figure Global Top 10 Players Cell Therapy Revenue Market Share in 2017
Figure Global Cell Therapy Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Cell Therapy Revenue (Million USD) by Regions (2013-2018)
Table Global Cell Therapy Revenue Market Share by Regions (2013-2018)
Figure Global Cell Therapy Revenue Market Share by Regions (2013-2018)
Figure Global Cell Therapy Revenue Market Share by Regions in 2017
Figure North America Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Europe Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Cell Therapy Revenue and Growth Rate (2013-2018)
Figure South America Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Cell Therapy Revenue and Growth Rate (2013-2018)
Table North America Cell Therapy Revenue by Countries (2013-2018)
Table North America Cell Therapy Revenue Market Share by Countries (2013-2018)
Figure North America Cell Therapy Revenue Market Share by Countries (2013-2018)
Figure North America Cell Therapy Revenue Market Share by Countries in 2017
Figure USA Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Canada Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Mexico Cell Therapy Revenue and Growth Rate (2013-2018)
Table Europe Cell Therapy Revenue (Million USD) by Countries (2013-2018)
Figure Europe Cell Therapy Revenue Market Share by Countries (2013-2018)
Figure Europe Cell Therapy Revenue Market Share by Countries in 2017
Figure Germany Cell Therapy Revenue and Growth Rate (2013-2018)
Figure UK Cell Therapy Revenue and Growth Rate (2013-2018)
Figure France Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Russia Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Italy Cell Therapy Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Cell Therapy Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Cell Therapy Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Cell Therapy Revenue Market Share by Countries in 2017
Figure China Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Japan Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Korea Cell Therapy Revenue and Growth Rate (2013-2018)
Figure India Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Cell Therapy Revenue and Growth Rate (2013-2018)
Table South America Cell Therapy Revenue by Countries (2013-2018)
Table South America Cell Therapy Revenue Market Share by Countries (2013-2018)
Figure South America Cell Therapy Revenue Market Share by Countries (2013-2018)
Figure South America Cell Therapy Revenue Market Share by Countries in 2017
Figure Brazil Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Argentina Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Colombia Cell Therapy Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Cell Therapy Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Cell Therapy Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Cell Therapy Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Cell Therapy Revenue Market Share by Countries in 2017
Figure Saudi Arabia Cell Therapy Revenue and Growth Rate (2013-2018)
Figure UAE Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Egypt Cell Therapy Revenue and Growth Rate (2013-2018)
Figure Nigeria Cell Therapy Revenue and Growth Rate (2013-2018)
Figure South Africa Cell Therapy Revenue and Growth Rate (2013-2018)
Table Global Cell Therapy Revenue (Million USD) by Type (2013-2018)
Table Global Cell Therapy Revenue Share by Type (2013-2018)
Figure Global Cell Therapy Revenue Share by Type (2013-2018)
Figure Global Cell Therapy Revenue Share by Type in 2017
Table Global Cell Therapy Revenue Forecast by Type (2018-2023)
Figure Global Cell Therapy Market Share Forecast by Type (2018-2023)
Figure Global Autologous Revenue Growth Rate (2013-2018)
Figure Global Allogeneic Revenue Growth Rate (2013-2018)
Table Global Cell Therapy Revenue by Application (2013-2018)
Table Global Cell Therapy Revenue Share by Application (2013-2018)
Figure Global Cell Therapy Revenue Share by Application (2013-2018)
Figure Global Cell Therapy Revenue Share by Application in 2017
Table Global Cell Therapy Revenue Forecast by Application (2018-2023)
Figure Global Cell Therapy Market Share Forecast by Application (2018-2023)
Figure Global Hospitals and clinics Revenue Growth Rate (2013-2018)
Figure Global ASCs Revenue Growth Rate (2013-2018)
Figure Global Regenerative medicine centers Revenue Growth Rate (2013-2018)
Figure Global Cell Therapy Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Cell Therapy Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Cell Therapy Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Cell Therapy Revenue Market Forecast (2018-2023)
Figure Europe Cell Therapy Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Cell Therapy Revenue Market Forecast (2018-2023)
Figure South America Cell Therapy Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Cell Therapy Revenue Market Forecast (2018-2023)
